Skip to main content
Premium Trial:

Request an Annual Quote

People in the News

Second Genome: Joseph Dal Porto

Joseph Dal Porto has been appointed as CSO of Second Genome. Previously, he was VP at Pfizer's emerging science & innovation division and site head of Pfizer's Centers for Therapeutic Innovation. Prior to that, he was a cofounder and director of preclinical research and development at Modus BioMedicine, a spinout from Roche. Dal Porto holds a PhD in microbiology and immunology from the University of Maryland School of Medicine and a BS in biochemistry from Johns Hopkins University.

UK Biobank: Mahesh Pancholi

Mahesh Pancholi has joined the UK Biobank as chief information officer. Previously, he was an enterprise account manager for genomics and life sciences research at Amazon Web Services, and prior to that, a business development manager at OCF. Before that, he was head of research computing at Queen Mary University of London, where he also received a bachelor's degree in genetics.

Caribou Biosciences: Syed Rizvi

Syed Rizvi has been appointed as chief medical officer of Caribou Biosciences, a new position at the company. Most recently, he served in the same role at Chimeric Therapeutics, and before that, he held various roles, including head and VP of clinical development, at Legend Biotech. Previously, he was head of global medical affairs for CAR-T cell programs and head of hematology and immuno-oncology for US medical affairs at Celgene. Rizvi holds a medical degree from Dow Medical College.

Uniogen: Ilari Antila, Tomi Numminen, Timo Lövgren, Johan Kronberg

Ilari Antila has been appointed as CEO of Uniogen, the Finnish company that emerged from the combination of Abacus Diagnostica, Kaivogen, and Labrox. He joins the firm from Injeq, where he was also CEO.

In addition, Uniogen appointed Tomi Numminen, Timo Lövgren, and Johan Kronberg to its board of directors.

M2Gen: Daniel Elgort, May Yoon

Oncology-focused bioinformatics company M2Gen has appointed Daniel Elgort as chief data and analytics officer and May Yoon as chief people officer.

Elgort was most recently CSO at Covera Health. where he built a healthcare data platform to collect cancer diagnosis data and link it to longitudinal clinical data. He holds BS degrees in biomedical engineering and computer science from Johns Hopkins University and a PhD in biomedical engineering from Case Western Reserve University.

Yoon previously served as chief people officer at Agio, a VC-backed IT firm; and at Clear, a biometric identify company. She holds bachelors degrees in international relations and psychology from Wellesley College and an MS in management and strategy from the London School of Economics.

CS Genetics: Jeremy Preston

Genomics technology company CS Genetics has named Jeremy Preston as chief commercial officer. Preston joins the company from Illumina, most recently serving as VP of regional and segment marketing. Earlier roles at Illumina included as VP of specialty sales and marketing and senior director of product marketing. Prior to Illumina, Preston was associate director of product marketing at Affymetrix. He completed his postdoc in molecular biology at Japan's Riken, and his PhD in molecular biology at La Trobe University in Melbourne.

Genomenon: Sean Kearney

Genomenon has appointed Sean Kearney as CFO. Kearney has more than ten years of experience in healthcare venture capital investing and operations that includes trading in public and private equity, commodity, and foreign exchange markets, Genomenon said. Prior to joining Genomenon, he founded and managed investment funds through private equity and venture capital markets. He holds an MBA from the Fisher College of Business at Ohio State University.

Akoya Biosciences: Marilee Moy

Akoya Biosciences has appointed Marilee Moy as its chief people officer. Prior to joining Akoya, Moy led human resources at Talis Biomedical after serving as VP of people at Counsyl, now part of Myriad Genetics. She has also held various HR leadership roles at Genentech, Abbott, Johnson & Johnson, and Nikon Precision. Moy holds a BA from Boston College and an MBA from Golden Gate University.

Foresight Diagnostics: Sandra Horning

Liquid biopsy-based cancer diagnostics firm Foresight Diagnostics has appointed Sandra Horning to its new scientific advisory board. She is a professor emerita at Stanford University and is a cofounder and board member of EQRx. She also serves on the boards of Gilead Sciences, Moderna, and Olema Oncology. Previously, Horning was CMO and head of global product development at Genentech/Roche.

Predicine: Clint Webb

Predicine has appointed Clint Webb as its new general counsel. Webb, who has specialized in advising high-growth diagnostic, biotech and device companies, previously served as head of legal at Visby Medical. He becan his legal career at Morrison & Foerster and has led legal and operations teams at public and private life science companies. According to Predicine, Webb is expected to be a key player in supporting the company's efforts to expand its liquid biopsy research platform and infectious disease capabilities.

The Scan

Transplant Tests Edited Pig Kidneys

The Associated Press reports a University of Alabama-Birmingham team transplanted genetically modified pig kidneys into a brain-dead human patient.

UK Changes Some Gene-Edited Crop Rules

A new law may enable gene-edited crops to be sold in the UK within about five years, New Scientist says.

Pill Works Against Omicron in Lab

Pfizer's antiviral pill to treat SARS-CoV-2 appears to work against the Omicron variant, the Wall Street Journal reports.

Nature Papers Find Genetic Risk Factor for Smell, Taste Loss in COVID-19; Analyze TB Granulomas

In Nature this week: genome-wide association study find locus linked to the risk COVID-19 patients losing their sense of taste or smell, and more.